These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

134 related items for PubMed ID: 7125407

  • 1. Vasodilators and prostaglandin inhibitors in primary pulmonary hypertension.
    Hermiller JB, Bambach D, Thompson MJ, Huss P, Fontana ME, Magorien RD, Unverferth DV, Leier CV.
    Ann Intern Med; 1982 Oct; 97(4):480-9. PubMed ID: 7125407
    [Abstract] [Full Text] [Related]

  • 2. Reassessment of the effects of vasodilator drugs in primary pulmonary hypertension: guidelines for determining a pulmonary vasodilator response.
    Rich S, Martinez J, Lam W, Levy PS, Rosen KM.
    Am Heart J; 1983 Jan; 105(1):119-27. PubMed ID: 6849224
    [No Abstract] [Full Text] [Related]

  • 3. Vasodilator therapy in primary pulmonary hypertension.
    Elkayam U.
    Chest; 1981 Mar; 79(3):253-4. PubMed ID: 7471853
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Vasodilators, modern therapeutic approach in pulmonary arterial hypertension].
    Gherasim L, Bogdan M.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1982 Mar; 34(2):97-102. PubMed ID: 6127777
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prostaglandin E1 as a screening vasodilator in primary pulmonary hypertension.
    Halpern SM, Shah PK, Lehrman S, Goldberg HS, Jasper AC, Koerner SK.
    Chest; 1987 Oct; 92(4):686-91. PubMed ID: 3652754
    [Abstract] [Full Text] [Related]

  • 13. Combination vasodilator therapy for severe chronic congestive heart failure.
    Chatterjee K, Drew D, Parmley WW, Klausner SC, Polansky J, Zacherle B.
    Ann Intern Med; 1976 Oct; 85(4):467-70. PubMed ID: 823852
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [New aspects in the treatment of acute cardiac insufficiency].
    Sterz H.
    Wien Med Wochenschr; 1978 May 15; 128(9):256-61. PubMed ID: 27016
    [No Abstract] [Full Text] [Related]

  • 16. Effects of dipyridamole and inhaled nitric oxide in pediatric patients with pulmonary hypertension.
    Ziegler JW, Ivy DD, Wiggins JW, Kinsella JP, Clarke WR, Abman SH.
    Am J Respir Crit Care Med; 1998 Nov 15; 158(5 Pt 1):1388-95. PubMed ID: 9817684
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effective control of refractory pulmonary hypertension after cardiac operations.
    Fullerton DA, Jaggers J, Piedalue F, Grover FL, McIntyre RC.
    J Thorac Cardiovasc Surg; 1997 Feb 15; 113(2):363-8; discussion 368-70. PubMed ID: 9040631
    [Abstract] [Full Text] [Related]

  • 20. Comparative actions of hydralazine, nifedipine and amrinone in primary pulmonary hypertension.
    Rich S, Ganz R, Levy PS.
    Am J Cardiol; 1983 Nov 01; 52(8):1104-7. PubMed ID: 6637831
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.